{\rtf1\ansi\deff0\deftab360

{\fonttbl
{\f0\fswiss\fcharset0 Arial}
{\f1\froman\fcharset0 Times New Roman}
{\f2\fswiss\fcharset0 Verdana}
{\f3\froman\fcharset2 Symbol}
}

{\colortbl;
\red0\green0\blue0;
}

{\info
{\author Biblio 7.x}{\operator }{\title Biblio RTF Export}}

\f1\fs24
\paperw11907\paperh16839
\pgncont\pgndec\pgnstarts1\pgnrestart
M. H.  Shaikh, Subhedar, D. D., Arkile, M. A., Khedkar, V. M., Jadhav, N. J., Sarkar, D., and Shingate, B. B., ?Synthesis and bioactivity of novel triazole incorporated benzothiazinone derivatives as antitubercular and antioxidant agent?, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 2, pp. 561-569, 2016.\par \par M. H.  Shaikh, Subhedar, D. D., Shingate, B. B., Khan, F. A. Kalam, Sangshetti, J. N., Khedkar, V. M., Nawale, L., Sarkar, D., Navale, G. R., and Shinde, S. S., ?Synthesis, biological evaluation and molecular docking of novel coumarin incorporated triazoles as antitubercular, antioxidant and antimicrobial agents?, Medicinal Chemistry Research, vol. 25, no. 4, pp. 790-804, 2016.\par \par S.  Gholap, Tambe, M., Nawale, L., Sarkar, D., Sangshetti, J., and Damale, M., ?Design, synthesis, and pharmacological evaluation of fluorinated azoles as anti-tubercular agents?, Archiv Der Pharmazie, vol. 351, no. 2, p. e1700294, 2018.\par \par V.  Shinde, Mahulikar, P., Mhaske, P. C., Nawale, L., and Sarkar, D., ?Synthesis and biological evaluation of new 2-aryl-4-((4-aryl-1H-1,2,3-triazol-1-yl)methyl)thiazole derivatives?, Research on Chemical Intermediates, vol. 44, no. 2, pp. 1247-1260, 2018.\par \par A. B.  Danne, ?Synthesis and biological evaluation of novel triazole-biscoumarin conjugates as potential antitubercular and anti-oxidant agents?, Research on Chemical Intermediates, vol. 44, no. 10, pp. 1-28, 2018.\par \par , ,, Wadgaonkar, P. P., Tapase, S. R., Kodam, K. M., Choudhari, A., and Sarkar, D., ?Click chemistry based multicomponent approach in the synthesis of spirochromenocarbazole tethered 1,2,3-triazoles as potential anticancer agents?, Bioorganic Chemistry, vol. 85, pp. 475-486, 2019.\par \par A. Atmaram Upare, Gadekar, P. K., Sivaramakrishnan, H., Naik, N., Khedkar, V. M., Sarkar, D., Choudhari, A., and S. Roopan, M., ?Design, synthesis and biological evaluation of (E)-5-styryl-1,2,4-oxadiazoles as anti-tubercular agents?, Bioorganic Chemistry, vol. 86, pp. 507-512, 2019.\par \par V.  Shinde, Mahulikar, P., Mhaske, P. C., Chakraborty, S., Choudhari, A., Phalle, S., Choudhari, P., and Sarkar, D., ?Synthesis and antimycobacterial evaluation of new 5-(1-benzyl-1H-1,2,3-triazol-4-yl)-4-methyl-2-arylthiazole derivatives?, Medicinal Chemistry Research, vol. 28, no. 6, pp. 805-819, 2019.\par \par S.  Sarkar, Swami, S., Soni, S. Kumar, Holien, J. K., Khan, A., Korwar, A. M., Likhite, A. P., Joshi, R. A., Joshi, R. R., and Sarkar, D., ?Detection of a target protein (GroEl2) in Mycobacterium tuberculosis using a derivative of 1,2,4-triazolethiols?, Molecular Diversity, vol. 26, no. 5, pp. 2535-2548, 2022.\par \par M. H.  Shaikh, Subhedar, D. D., Akolkar, S. V., Nagargoje, A. A., Khedkar, V. M., Sarkar, D., and Shingate, B. B., ?Tetrazoloquinoline-1,2,3-triazole derivatives as antimicrobial agents: synthesis, biological evaluation and molecular docking study?, Polycyclic Aromatic Compounds, vol. 42, no. 4, pp. 1920-1941, 2022.\par \par }